News
A study postulates vaginal self-sample and urine as applicable tools for endometrial cancer diagnosis and prognosis
Two studies led by IDIBELL and the Catalan Institute of Oncology show that DNA sequencing in these samples can detect endometrial cancer, which would avoid much more invasive and painful methods.
IDIBELL and CIBER researchers identify a new genetic disease that affects the development of the nervous system and causes liver failure
RINT1 mutations would be causing a deregulation of fat metabolism and intracellular communication of energy production. This is a significant advance in the understanding of this disease, and opens new perspectives for diagnosis and possible treatment in the future.
New collaboration with Blue Zone Studio to create an OCD monitoring application
The application will monitor in real-time and, combined with neuroimaging studies, will allow the identification of new biomarkers to predict the disease evolution.
Study of brain lesions reveals key connections in epilepsy
A team of researchers including scientists from the Bellvitge Campus, has made a map of lesions of different nature related to epilepsy and discovered that the alteration of a specific neural circuit was common to all the lesions studied.
The natural antioxidant L-Ergothioneine prevents the formation of cystine stones in a murine model of cystinuria
Treatment with L-Ergothioneine manages to increase the solubility of cystine in urine, thus preventing the formation of stones or delaying their appearance. After treatment, an improvement in the oxidative status and mitochondrial function in the kidney is also observed. If these results are validated in future clinical trials, a new preventive treatment for this disease would be available.
Researchers outline the mechanisms that control the conversion between fetal and adult intestinal stem cells
In the two published studies, the scientific team uses the intestine organoid as a model, a three-dimensional structure similar to mini-intestines created in the laboratory from stem cells. Deciphering the functioning of some transcription factors in the formation of the intestine has been the objective of the team.
La Fundación Vela Clásica de España donates 20,000 euros for ALS Research
Valle de la Riva, President of the Foundation, gave the check to Mònica Povedano, IDIBELL researcher and neurologist at the Hospital de Bellvitge, during the first day of the Puig Vela Clássica.
New collaboration agreement with the ICR and Vivan Therapeutics to design new personalized treatments against cancer
A collaboration has been signed between the Bellvitge Biomedical Research Institute (IDIBELL), the Institute of Cancer Research (ICR) in London, and Vivan Therapeutics to jointly develop molecules that recognize more than one target for personalized treatment of colorectal cancer.
Barcelona becomes the European scientific capital of ALS thanks to the ENCALS International Congress
The local person in charge of the congress is Dra. Mònica Povedano, coordinator of the Motor Neuron Disease Functional Unit of the Bellvitge University Hospital (HUB) and principal researcher of the research group on Neurological and Neurogenetic Diseases of IDIBELL.